Principal Scientist / Associate Director
Discovery Biology and Gene Editing, Durham
Confirmed live in the last 24 hours
ReCode Therapeutics

51-200 employees

Develops targeted mRNA and gene correction therapeutics
Company Overview
ReCode Therapeutics, a clinical-stage genetic medicines company, distinguishes itself through its proprietary selective organ targeting (SORT) lipid nanoparticle (LNP) platform, a technology that enables precise delivery of genetic medicines to target organs and cells beyond the liver. The company's leadership, including Ms. Jefferson, boasts extensive experience in biopharma and public health communications, with a track record of strategic roles at the U.S. FDA and other notable biopharma companies. This blend of technical prowess and industry leadership positions ReCode Therapeutics as a competitive player in the genetic medicines field.
Data & Analytics

Company Stage

Series B

Total Funding





Menlo Park, California

Growth & Insights

6 month growth


1 year growth


2 year growth

Durham, NC, USA
Experience Level
Desired Skills
Biology & Biotech
  • PhD in molecular biology, cell biology or related discipline with 4-6 years of experience in postdoctoral research and/or industry
  • Expertise in primary human cell culture and/or non-human primate / murine preclinical disease models and related experimental work
  • Prior experience in a BSL2 or more environment
  • Prior working knowledge of gene editing modalities and tools, such as double-stranded break cutters, base editors and prime editors; and knowledge of associated analytic assays (e.g. Western blot, ddPCR, qPCR), including NGS methods for interrogating editing outcomes
  • Applying gene editing tools for cell engineering, genomics studies, and/or therapeutic development
  • Experience with viral or non-viral delivery platforms, preferably lipid nanoparticles (LNPs)
  • Advanced knowledge of statistical and genome analytical tools (GraphPad, R, SnapGene)
  • Key competencies for this position include but not limited to: technical expertise, collaboration, communication and inspirational leadership
  • Project Team Leader for one or more projects at the discovery and early development phase, applying gene correction solutions for lung disease targets
  • Lead a cross functional drug discovery team that includes gene editing, cell biology, computational biology, bioanalytical, toxicology and formulation/CMC
  • Contribute to the discovery and early preclinical research plans, including defining key milestones and decision points and timelines, identifying risks and mitigation strategies towards later development and IND filings
  • Design, oversee and execute gene editing experiments, applying advanced molecular techniques and assays in a therapeutic drug discovery workflow
  • Oversee project management activities, identify and manage project objectives, work plans, timelines, budgets, providing formal and informal status updates to stakeholders as needed
  • Oversee the design and execution disease-relevant assays across diverse therapeutic applications internally and through CRO partners
  • Ensure site-wide electronic lab notebook and record keeping complies with with company policies
  • Interface with R&D Senior Management on project requirements, status review, and key development decisions
  • Contribute to preclinical strategy, vision, and operation